Cargando…
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action
Looking for new metal-based anticancer treatments, in recent years many ruthenium complexes have been proposed as effective and safe potential drugs. In this context we have recently developed a novel approach for the in vivo delivery of Ru(III) complexes, preparing stable ruthenium-based nucleolipi...
Autores principales: | Irace, Carlo, Misso, Gabriella, Capuozzo, Antonella, Piccolo, Marialuisa, Riccardi, Claudia, Luchini, Alessandra, Caraglia, Michele, Paduano, Luigi, Montesarchio, Daniela, Santamaria, Rita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368645/ https://www.ncbi.nlm.nih.gov/pubmed/28349991 http://dx.doi.org/10.1038/srep45236 |
Ejemplares similares
-
Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems
por: Ferraro, Maria Grazia, et al.
Publicado: (2020) -
Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem
por: Ferraro, Maria Grazia, et al.
Publicado: (2023) -
Safety and Efficacy Evaluation In Vivo of a Cationic Nucleolipid Nanosystem for the Nanodelivery of a Ruthenium(III) Complex with Superior Anticancer Bioactivity
por: Piccolo, Marialuisa, et al.
Publicado: (2021) -
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer
por: Piccolo, Marialuisa, et al.
Publicado: (2019) -
Investigating the Interaction of an Anticancer Nucleolipidic Ru(III) Complex with Human Serum Proteins: A Spectroscopic Study
por: Riccardi, Claudia, et al.
Publicado: (2023)